The legal landscape is moving faster than almost any policy area. Oregon and Colorado both have operational licensed frameworks. Australia approved ketamine and MDMA therapy in 2023. Here is the current state — accurately.
Voters approved regulated psilocybin therapy services — the world's first. The Oregon Health Authority spent 2021–2023 building the licensing framework.
Colorado voters approved regulated psilocybin (and eventually other psychedelics) for licensed healing centres. Natural Medicine Health Act — broader than Oregon's framework.
The Oregon Psilocybin Services programme begins. Licensed facilitators, licensed service centres, regulated product manufacturers. Fully operational legal framework in place.
Australia becomes the first country to schedule MDMA and psilocybin as Approved Medicines for specific psychiatric conditions. Psychiatrists can now prescribe — a landmark global first.
FDA's Complete Response Letter citing data concerns delays MDMA-assisted therapy approval. MAPS continues Phase 3 trials and prepares resubmission with additional data.
Colorado's Natural Medicine Health Act framework becomes fully operational. Psilocybin healing centres open. The framework eventually expands to include mescaline, DMT, and ibogaine.
Oregon's programme continues scaling. Multiple jurisdictions watching Oregon and Colorado data before considering similar frameworks. International legal momentum building.
| Country/Jurisdiction | Psilocybin | Ayahuasca | Ketamine | MDMA | Ibogaine |
|---|---|---|---|---|---|
| Oregon (USA) | ✓ Licensed centres | Illegal | ✓ Prescription | Trials only | Illegal |
| Colorado (USA) | ✓ Healing centres | Illegal | ✓ Prescription | Trials only | Illegal |
| Other US States | Illegal (federal) | Illegal | ✓ Nationwide | Trials only | Schedule I |
| Australia | ✓ Psychiatrist prescription | Illegal | ✓ TGA approved | ✓ Psychiatrist prescription | Illegal |
| Netherlands | ✓ Truffles legal | ✓ Legal | ✓ Prescription | ✓ Legal (personal use) | Illegal |
| Jamaica | ✓ No prohibition | ✓ Legal | ✓ Prescription | ✓ Legal | ✓ Legal |
| Costa Rica | Illegal | ✓ Tolerated/legal | ✓ Available | Illegal | Illegal |
| Peru | ✓ Native plant tradition | ✓ Legal (native plant) | ✓ Medical | Illegal | Illegal |
| Mexico | ✓ Decriminalised / tolerated | ✓ Tolerated | ✓ Medical | Illegal | ✓ Legal |
| UK | Class A | Illegal | ✓ Prescription | Trials only | Class A |
| Canada | Trials/exemptions only | Illegal | ✓ Legal | Trials only | Illegal |
Legal status is more nuanced than a simple yes/no. Here are the three main categories:
Fully legalised with regulatory framework: Oregon and Colorado psilocybin — requires licensed facilitators, licensed service centres, regulated supply chains. The model closest to Western medical care. Highest safety standards, typically highest cost.
Legal with no prohibition: Jamaica (psilocybin, MDMA, ibogaine — never prohibited), Netherlands (psilocybin truffles, MDMA personal use) — legal retreat operations run without needing state licensing frameworks. Safety depends entirely on the retreat's own protocols.
Tolerated/Ceremonial use protected: Peru and Costa Rica for ayahuasca — traditional plant use is recognised as cultural heritage. Commercial retreat operations exist in a legal grey zone that is broadly accepted but not formally regulated. Safety standards vary enormously between operators.